Junqiang Chen

6PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapySocial epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 16, 2026
The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study.

Qi Liu, Junqiang Chen, Wenbin Shen

|Nov 20, 2024
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.

Yu Lin, Wenbin Shen, Jinjun Ye

|Nov 03, 2022
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.

Weiming Han, Lan Wang, Chen Li

|Jan 06, 2022
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.

Xiao Chang, Junqiang Chen, Wencheng Zhang

|Jan 17, 2020
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).

Mingqiu Chen, Xiaohong Liu, Chun Han

|Aug 06, 2017
Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.

J Chen, T Su, Y Lin

Pageof 1

Frequent Collaborators

2 joint publications

Zefen Xiao

2 joint publications

Wenyang Liu

2 joint publications

Conghua Xie

2 joint publications

Qi Liu